AIM

Amendment - 2023 Full Year Financial Results

Retrieved on: 
Tuesday, March 26, 2024
Financial statement, Environmental impact assessment, Icelandic, Vein, Government, Mining, Growth, Fundraising, Bed, OMX, FY, Nanoq, ESG, Webcast, Corporation, Gold, Copper, Q4, Rehabilitation, Social impact assessment, SIA, Capital market, REE, Niobium, IOCG, Workforce, Unit, EIA, AIM, Nasdaq Iceland, Engineering, Person, Rare-earth element

Amendments have been made to the ‘2023 Full Year Financial Results’ announcement released on 26 March 2024 at 07:00 in the Financial Results table.

Key Points: 
  • Amendments have been made to the ‘2023 Full Year Financial Results’ announcement released on 26 March 2024 at 07:00 in the Financial Results table.
  • “We experienced some operational and procurement delays towards the end of 2023 due to adverse weather conditions, which continued into the start of 2024.
  • Amaroq will continue to review the results of the detailed geophysical programme conducted over the Kobberminebugt licence in 2023.
  • The following selected financial data is extracted from the Financial Statements for the three months ended December 31, 2023.

Falcon Oil & Gas Ltd - Shenandoah South - 1H well IP60 Day Flow Rates of 3.0 MMcf/d (normalised to 6.0 MMcf/d)

Retrieved on: 
Tuesday, March 26, 2024
EUR, Pressure, JV, FOG, Beetaloo, IP90, AIM, Oil

26 March 2024 – Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce that the Shenandoah South 1H (SS-1H) well in EP117 achieved above commercial IP60 flow rate of 3.0 MMcf/d (normalised to 6.0 MMcf/d over 1,000 metres).

Key Points: 
  • 26 March 2024 – Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce that the Shenandoah South 1H (SS-1H) well in EP117 achieved above commercial IP60 flow rate of 3.0 MMcf/d (normalised to 6.0 MMcf/d over 1,000 metres).
  • Flow testing of the SS-1H well will continue for the next 30 days to achieve average IP90 flow rates to better determine the well’s estimated ultimate recovery per well (EUR).
  • The project is expected to require six 10,000-foot development wells initially to achieve plateau production of 40 MMcf/d.
  • This augurs well for the initial development in the Shenandoah South area as these rates continue to track average flow rates seen in the Marcellus Shale basin in the US.”

2023 Full Year Financial Results

Retrieved on: 
Tuesday, March 26, 2024
Financial statement, Environmental impact assessment, Icelandic, Vein, Government, Mining, Growth, Fundraising, Bed, OMX, FY, Nanoq, ESG, Webcast, Corporation, Gold, Copper, Q4, Rehabilitation, Social impact assessment, SIA, Capital market, REE, Niobium, IOCG, Workforce, Unit, EIA, AIM, Nasdaq Iceland, Engineering, Person, Rare-earth element

“We experienced some operational and procurement delays towards the end of 2023 due to adverse weather conditions, which continued into the start of 2024.

Key Points: 
  • “We experienced some operational and procurement delays towards the end of 2023 due to adverse weather conditions, which continued into the start of 2024.
  • Contracting and Procurement: At the end of Q4 2023, 80% of the key contracts for the processing plant were concluded and procurement was 80% completed.
  • Amaroq will continue to review the results of the detailed geophysical programme conducted over the Kobberminebugt licence in 2023.
  • The following selected financial data is extracted from the Financial Statements for the three months ended December 31, 2023.

Strategic Review Supports Continued Production Ramp-Up at North American Lithium

Retrieved on: 
Tuesday, April 9, 2024
Technology, General Automotive, Chemicals, Plastics, EV, Electric Vehicles, Manufacturing, Alternative Vehicles, Fuels, Automotive, Batteries, Alternative Energy, Energy, Vehicle Technology, Other Natural Resources, Mining, Minerals, Natural Resources, Lithium, Element, Piedmont Lithium, 600 (number), Comment, NAL, Atlantic Ocean, ALL, ASX, PLL, Acquisition, Transport, SYA, Risk, XV, Accident, Australian Securities Exchange, Workforce, AIM, Legislation, Weather

Production at NAL commenced in March 2023, and the operations have been undergoing steady improvement.

Key Points: 
  • Production at NAL commenced in March 2023, and the operations have been undergoing steady improvement.
  • March month-to-date lithium recoveries were 69%, exceeding the ramp-up target of 67%, with global recovery of 62% during the July 2023 through March 2024 period.
  • Production of spodumene concentrate has steadily increased with several daily production records achieved in March 2024, including the newest daily production record of 740 metric tons.
  • The joint venture partners have conducted an operational review to assess the pace of the production ramp-up in the context of a challenging lithium price environment.

UMD Launches Institute Focused on Ethical AI Development

Retrieved on: 
Tuesday, April 9, 2024
Machine learning, Learning, Computer science, Intelligence, Education, Trust (social science), Research, Artificial intelligence, University, Faculty, Student, Creativity, Workforce, UMD, TRAILS, AIM, Government, Engineering, Journalism, Teaching, Medical device

COLLEGE PARK, Md., April 9, 2024 /PRNewswire/ -- The University of Maryland today announced the launch of a new institute dedicated to developing the next generation of artificial intelligence (AI) education, technology and leaders.

Key Points: 
  • "Establishing the AI Interdisciplinary Institute at Maryland is a pioneering step in AI research and education," said University of Maryland President Darryll J. Pines.
  • With this institute, our experts will work together to globally lead responsible AI development that spurs economic growth and promotes human well-being.
  • The new institute builds upon the university's existing AI expertise, research and centers, including the Center for Machine Learning, the National Science Foundation-funded Institute for Trustworthy AI in Law & Society (TRAILS), the Value-Centered AI Initiative and the Social Data Science Center.
  • The institute will coordinate:
    In addition to the existing, 100-plus faculty members who study and teach AI, the university expects to hire additional faculty in foundational and interdisciplinary AI, and staff to work within the institute.

Mkango Raises £750,000 (C$1.3M) to Advance Rare Earth Magnet Recycling in United Kingdom and Germany, and Launches Strategic Review

Retrieved on: 
Monday, March 25, 2024
Hydrogen, Magnet, HPMS, Exercise, DTR, Neodymium magnet, Recycling, Minority, Disclosure, Research, Acquisition, University, Carbonate, Treasury, Admission, MKA, AIM, Subscription business model, Multilateral

LONDON and VANCOUVER, British Columbia, March 25, 2024 (GLOBE NEWSWIRE) -- Mkango Resources Ltd. (AIM/TSX-V: MKA) is pleased to announce that it has conditionally raised gross proceeds of £750,000 (approximately C$1.3 million) through the issuance, on a private placement basis, of 15,000,000 common shares of the Company (the “Subscription Shares”) at a price per Subscription Share of 5 pence (“p”) (approximately C$0.086) (the “Subscription”).

Key Points: 
  • As part of this process, the Company has decided to launch a review of strategic options for its Songwe Hill Rare Earths Project in Malawi as well as the Pulawy Rare Earths Separation Project in Poland.
  • Mkango believes this strategic review will help maximise returns for its shareholders whilst it seeks to expand its recycling business.”
    HyProMag is commercialising Hydrogen Processing of Magnet Scrap (“HPMS”) recycling technology in the UK, Germany and United States.
  • William Dawes, CEO and a director of the Company, has agreed to subscribe for 3,000,000 Subscription Shares, for £150,000.
  • The issuance of the Subscription Shares to William Dawes was approved by the board of directors of Mkango, with William Dawes abstaining from voting.

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

Retrieved on: 
Monday, March 25, 2024
Ovarian cancer, Gene, Clinical Cancer Research, Erasmus MC, Data analysis, Colorectal cancer, Progression-free survival, Patient, Neoplasm, Triple-negative breast cancer, Tumor microenvironment, Manuscript, Pancreatic cancer, Cancer, Doctor of Philosophy, MD, Epithelium, PD-L1, AIM, Liver, RNA, Vaccine

The manuscript titled “ Rintatolimod in Advanced Pancreatic Cancer enhances Anti-Tumor Immunity through Dendritic Cell-Mediated T Cell Responses ,” appears in the journal Clinical Cancer Research, one of oncology’s most prestigious journals.

Key Points: 
  • The manuscript titled “ Rintatolimod in Advanced Pancreatic Cancer enhances Anti-Tumor Immunity through Dendritic Cell-Mediated T Cell Responses ,” appears in the journal Clinical Cancer Research, one of oncology’s most prestigious journals.
  • Ampligen is a dsRNA product candidate that acts via the TLR-3 receptor present on several immune cells, epithelial cells and tumors.
  • Post-Ampligen, the increased peripheral abundance of BTLA+XCR1+ cDC1s and CD4+SELL+ T cells correlated with improved clinical outcomes.
  • Additionally, the changes in the tumor microenvironment we see in pancreatic cancer are similar to those we have seen in triple-negative breast cancer, ovarian cancer and colorectal cancer metastatic to the liver.

Falcon Oil & Gas Ltd. - Falcon Optimises its Interest in the Beetaloo

Retrieved on: 
Monday, March 25, 2024
Beetaloo, AIM, Aircraft pilot, Silviculture

The election by Falcon to reduce its working interest to 5% will significantly reduce Falcon’s cost to participate in the Pilot.

Key Points: 
  • The election by Falcon to reduce its working interest to 5% will significantly reduce Falcon’s cost to participate in the Pilot.
  • Falcon participated in the SS1-H well in 2023 at its 22.5% working interest which created a Drill Spacing Unit (“DSU”) of 20,480 acres.
  • Falcon retains its full 22.5% participation interest in the remaining 4.52 million acres in the Beetaloo, net 1 million acres to Falcon.
  • This election by Falcon demonstrates our ability to optimise our interest in the Beetaloo for the benefit of shareholders.

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Retrieved on: 
Friday, March 22, 2024
AIM, Virtual

OCALA, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website.

Key Points: 
  • OCALA, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website.
  • For the CEO Corner segment, Thomas Equels, Chief Executive Officer of AIM ImmunoTech, provided a corporate overview, a business outlook and discussed the AIM opportunity as part of the Virtual Investor Lunch Break series.

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Retrieved on: 
Wednesday, March 20, 2024
Ovarian cancer, AIM, Education minister

OCALA, Fla., March 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website.

Key Points: 
  • OCALA, Fla., March 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website.
  • For the CEO Corner segment, Thomas Equels, Chief Executive Officer of AIM ImmunoTech, provides an overview of Advanced Recurrent Ovarian Cancer and its unmet need, as well as the Company’s associated milestones with its clinical development program.